 |
NeuroSense Therapeutics
Last updated: May 05, 2024
Founder Alon Ben-Noon
Country: Israel | Funding: $20M (+)
Website: https://www.neurosense-tx.com/
NeuroSense Therapeutics is a clinical stage drug development company offering ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases. Focused on a combined therapy, targeting multiple pertinent MoAs in these complex diseases.
Website: https://www.neurosense-tx.com/
NeuroSense Therapeutics is a clinical stage drug development company offering ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases. Focused on a combined therapy, targeting multiple pertinent MoAs in these complex diseases.
